Delivery Order SPE2DB24D2003-SPE2DB24FXCW4
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,758.99 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical company AmerisourceBergen Corporation. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract has a potential value of $1,521.50 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is a prime contractor under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,357.03 to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,535.60, is for the procurement of 4563589249 LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a completion date of February 8, 2024. This delivery order is issued under an...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,068.84 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,806.80 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication, with a completion date of February 5, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The $1,780.07 firm fixed price contract has a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a potential value of $2,764.86. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,079.10 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a completion date of February 16, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $2,733.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to support government healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA,...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB24FXCW4Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,310.30 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities worldwide in support of the Department of Defense. The current award is a firm fixed price task order issued under this IDC. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/27/24 |